BioSpace News Archive

Biotech Beach

ChromaDex to Launch Niagen+, the First-Of-Its-Kind Pharmaceutical-Grade Intravenous and Injectable Niagen® (Patented Nicotinamide Riboside Chloride or NRC)

ChromaDex Corp., the global authority on nicotinamide adenine dinucleotide research and its application to healthy aging, unveils Niagen+, the first-of-its-kind pharmaceutical-grade Niagen®.

June 13, 2024
·
9 min read
BANOOK GROUP DEPLOYS GROWTH STRATEGY WITH ACQUISITIONS OF KEOSYS AND B.RESEARCH

Nancy, France, June 11, 2024 - Banook Group, global provider of technology and services for clinical trial operators, today announces two strategic acquisitions that enhance its offerings in central imaging and eCOA.

June 13, 2024
·
5 min read
FDA

UroGen Announces Unprecedented 82.3% Duration of Response at 12 Months in the ENVISION Trial Investigating UGN-102 as Potentially the First FDA-Approved Non-Surgical Treatment for LG-IR-NMIBC

UroGen Pharma Ltd. announced 82.3% 12-month duration of response data by Kaplan-Meier estimate from its Phase 3 ENVISION trial in patients who achieved complete response at three months after the first instillation of investigational drug UGN-102 for intravesical solution.

June 13, 2024
·
8 min read
BioMidwest

GT Molecular Announces an Ultra-Sensitive RT-PCR Multiplex Panel for Eight Key KRAS G12-G13 Mutations

GT Molecular, Inc. is adding to its cancer molecular assay product line with a multi-target RT-PCR assay kit featuring robust quality control metrics and internal process controls.

June 13, 2024
·
2 min read
BioMidwest

Cole-Parmer Is Back in Peristaltic Pumps

Cole-Parmer, an Antylia Scientific company, is pleased to reintroduce peristaltic pumps to enhance its industry-leading line of fluid handling solutions.

June 13, 2024
·
2 min read
Press Releases

U.S. Biopreservation Market Size to Reach USD 23.05 Billion by 2033

June 13, 2024
·
16 min read
Policy

Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)

Nexalin Technology, Inc. announced that its second generation, 15 milliamp neurostimulation device has been granted regulatory approval by the Brazilian Health Regulatory Agency, a regulatory body of the Brazilian government responsible for approving new drugs and medical devices.

June 13, 2024
·
3 min read
Biotech Bay

New Article Published in Science Highlights the Potential of ReCode Therapeutics’ Systemic Lung Delivery and CFTR Gene Correction

ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, announced the publication of a research article in Science.

June 13, 2024
·
3 min read